Marker profiling: An approach for quality evaluation of Indian medicinal plants

Drug Information Journal

Volumn 45, Issue 1, 2011, Pages 1-14

  Mukherjee, Pulok K ^a   Ponnusankar, S ^a   Venkatesh, P ^a   Gantait, Arunava ^a   Pal, Bikas C ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Indian medicinal plants; Marker profiling; Quality control

Indexed keywords

ADHATODA VASICA EXTRACT; ALLICIN; ALPHA ASARONE; BETA ASARONE; BIOCHEMICAL MARKER; CALAMINE; CAMPHENE; CARVACROL; CARYOPHYLLENE; CINEOLE; ECHINACEA ANGUSTIFLORA EXTRACT; EPHEDRA SINICA EXTRACT; EPHEDRINE; ESTRAGOLE; EUGENOL; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENOSIDE; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; LINALOOL; METHYLEUGENOL; NATURAL PRODUCT; NEROL; OCIMUM SANCTUM EXTRACT; SILYBUM MARIANUM EXTRACT; SILYMARIN; UNINDEXED DRUG; VASICINE;

ACORUS CALAMUS; ADHATODA; ASTHMA; BASIL; BRAIN DISEASE; BRONCHOSPASM; COGNITIVE DEFECT; COLD; COUGHING; DEPRESSION; DNA FINGERPRINTING; DRUG EFFICACY; DRUG MARKETING; ECHINACEA; EPHEDRA; EPHEDRA SINICA; GALLBLADDER DISEASE; GARLIC; GINKGO BILOBA; GINSENG; HERBAL MEDICINE; HYPERICUM PERFORATUM; HYPOCHOLESTEROLEMIA; HYPOGLYCEMIA; HYPOTENSION; LIVER DISEASE; MEDICINAL PLANT; NEOPLASM; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SILYBUM MARIANUM; SORE THROAT; SPLEEN DISEASE; STANDARDIZATION; WEIGHT REDUCTION;

EID: 78751548968     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286151104500101     Document Type: Review

References (61)

1. Mukherjee PK, Rai S, Kumar V, Mukherjee K, Hyland PJ, Hider RC. Plants of Indian origin in drug discovery. Expert Opin Drug Discov. 2007;2:633-657. (Pubitemid 47071656)
2. Mukherjee PK. Evaluation of Indian traditional medicine. Drug Inf J. 2001;35:631-640.
3. Mukherjee PK, Wahile A. Integrated approaches towards drug development from Ayurveda and other Indian system of medicines. J Ethnopharmacol. 2006;103:25-35. (Pubitemid 41681139)
4. Khan IA. Issues related to botanicals. Life Sci. 2006;78:2033-2038.
5. Mukherjee PK, ed. Quality Control of Herbal Drugs: An Approach to Evaluation of Botanicals. New Delhi: Business Horizons; 2002.
6. Mukherjee PK, Verpoorte R, eds. GMP for Botanicals: Regulatory and Quality Issues on Phytomedicines. New Delhi: Business Horizons; 2003.
7. Mukherjee PK, Houghton P, eds. Evaluation of Herbal Medicinal Products. Pharmaceutical Press, Royal Pharmaceutical Society of Great Britain; 2009.
8. Markers and natural health products. Technol Watch. 2006;3(1):2-4.
9. Busse W. The significance of quality for efficacy and safety of herbal medicinal products. Drug Inf J. 2000;34(1):15-23.
10. Srinivasan VS. Challenges and scientific issues in the standardization of botanicals and their preparations. United States Pharmacopoeia's dietary supplement verification program - a public health program. Life Sci. 2006;78:2039-2043.
11. Mueller A, Antus S, Bittinger M, et al. Chemistry and pharmacology of antiasthmatic Galphimia glauca, Adhatoda vasica, and Picrorhiza kurrooa. Planta Med. 1993;59:586-587.
12. World Health Organization. The Use of Traditional Medicine in Primary Health Care: A Manual for Health Workers in South-East Asia. New Delhi: SEARO Regional Health Papers, No 19; 1990: 1-2.
13. Soni MG, Carabin IG, Griffiths JC, Burdock GA. Safety of ephedra: lessons learned. Toxicol Lett. 2004;150(1):97-110.
14. Lee MK, Cheng BW, Che CT, Hsieh DP. Cytotoxicity assessment of Ma-huang (ephedra) under different conditions of preparation. Toxicol Sci. 2000;56(2):424-430.
15. Lee MK, Wong YK, Che CT, Hsieh DPH. Adrenergic agonists effects and cyto-toxicity of Chinese ephedra (Ma-huang) used for weight reduction. Toxicologist. 1999;48(1S):58.
16. Bye C, Dewsbury D, Peck AW. Effects on the human central nervous system of the two isomers of ephedrine and triprolidine and their interaction. Br J Clin Pharmacol. 1974;1(1):71-78.
17. Tashkin DP, Meth R, Simmons DH, Lee YE. Double-blind comparison of acute bronchial and cardiovascular effects of oral terbutaline and ephedrine. Chest. 1975;68:155-161.
18. Nuotto E. Psychomotor, physiological and cognitive effects of scopalamine and ephedrine in healthy men. Eur J Clin Pharmacol. 1983;24:603-609. (Pubitemid 13092236)
19. Rainone F. Milk thistle. Am Fam Physician. 2005;72(2):1285.
20. Gazak R, Svobodova A, Psotova A. Oxidized derivatives of silybin and their antiradical and antioxidant activity. Bioorg Med Chem. 2004;12:5677-5687.
21. Katiyar S. Silymarin and skin cancer prevention: anti-inflammatory, antioxidant and immunomodulatory effects (review). Int J Oncol. 2005; 26(1):169-176.
22. Ramasamy K, Agarwal R. Multitargeted therapy of cancer by silymarin mini-review. Cancer Lett. 2008;269(2):352-362.
23. Thomson M, Al-Amin ZM, Al-Qattan KK, Shaban LH, Ali M. Anti-diabetic and hypolipidaemic properties of garlic (Allium sativum) in streptozotocin-induced diabetic rats. Int J Diabetes Metabol. 2007;15(1):108-115.
24. Banerjee SK, Mukherjee PK, Maulik SK. Garlic as an anti-oxidant: the good, the bad and the ugly. Phytother Res. 2003;17(2):97-106.
25. Augusti KT. Therapeutic values of onion (Allium cepa L.) and garlic (Allium sativum L.). Indian J Exp Biol. 1996;34:634-640.
26. Hassan HT. Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy. Leuk Res. 2004;28:667-671.
27. Stoll V, Seebeck E. Allium compounds. I. Alliin the true mother compound of garlic oil. Helv Chem Acta. 1948;31(1):189-210.
28. Sen P. Therapeutic potentials of Tulsi: from experience to facts. Drugs News Views. 1993;1(2):15-21.
29. Palit G, Singh SP, Singh N, Kohli RP, Bhargava KP. An experimental evaluation of anti-asthmatic plant drugs from ancient Ayurvedic medicine. Aspects Aller Appl Immunol. 1983;16:36-41.
30. Prajapati ND. A Handbook of Medicinal Plants: A Complete Source Book. Agrobios, India; 2004: Section II, p. 367.
31. Greeson JM, Sanford B, Monti DA. St. Johns wort (Hypericum perforatum): a review of the current pharmacological, toxicological and clinical literature. Psychopharmacology. 2001;153:402-414.
32. Vijayan P, Vinodkumar S, Dhanaraj SA, Mukherjee PK, Suresh B. In vitro cytotoxicity and antitumour properties of Hypericum mysorense and Hypericum patulum. Phytother Res. 2003;17:952-956.
33. Mukherjee PK, Wahile A, Nazeer KFH, Rajan S. Hypericum source of natural antimicrobials. Oriental Pharm Exp Med. 2003;3(3):111-122.
34. Mukherjee PK, Saritha GS, Suresh B. Antimicrobial potentials of two different hypericum species available in India. Phytother Res. 2002;16: 692-695.
35. Mukherjee PK, Kumar V, Mal M, Houghton PJ. Acorus calamus: scientific validation of Ayurvedic tradition from natural sources. Pharm Biol. 2007;45:651-666.
36. Venkatesh P, Mukherjee PK, Satheeshkumar N, et al. Anti-allergic activity of standardized extract of Albizia lebbeck with reference to catechin as a phytomarker. Immunopharmacol Immunotoxicol. 2010; DOI: 10.3109/ 08923970903305481.
37. Kumar V, Mukherjee K, Satheeshkumar N, Mal M, Mukherjee PK. Validation of HPTLC method for the analysis of taraxerol in Clitoria ternatea. Phytochem Anal. 2008;19(3):244-250.
38. Mainak Mal, Souvik Basak, Wahile A, et al. HPTLC analysis of turmeric (Curcuma longa Linn.) containing formulations and food additives using curcumin as marker. Paper presented at the Drug Information Association annual meeting, Washington, DC, June 26-30, 2005.
39. Gantait A, Pandit S, Nema N, Mukherjee PK. Quantification of glycyrrhizin in Glycyrrhiza glabra extract by validated HPTLC densitometry. J AOAC Int. 2010;93(2):492-495.
40. Kumar NS, Mukherjee PK, Bhadra S, Saha BP, Pal BC. Acetylcholinesterase inhibitory potential of a carbazole alkaloid, mahanimbine, from Murraya koenigii. Phytotherapy Res. 2010;24:629-631.
41. Mukherjee D, Biswas A, Bhadra S, et al. Exploring the potential of Nelumbo nucifera rhizome on membrane stabilization, mast cell protection, nitric oxide synthesis and expression of costimulatory molecules. Immunopharmacol Immunotoxicol. 2010;32:466-472.
42. Ponnusankar S, Pandit S, Venkatesh M, Badyopadhyay A, Mukherjee PK. Cytochrome P450 inhibitory effect of standardized extract of Terminalia chebula. Phytother Res. 2010; July 11, Epub ahead of print.
43. Satheeshkumar N, Mukherjee PK, Bhadra S, Saha BP. Acetylcholinesterase enzyme inhibitory potential of standardized extract of Trigonella foenum graecum L and its constituents. Phytomedicine. 2009;17:292-295.
44. Rai, Mukherjee K, Mal M, Wahile A, Saha BP, Mukherjee PK. Determination of 6-gingerol in ginger (Zingiber officinale) using high-performance thin-layer chromatography. J Sep Sci. 2006;29:2292-2295.
45. Ernst E. The risk-benefit profile of commonly used herbal therapies: ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava. Ann Int Med. 2002;136:42-53.
46. Burger RA, Torres AR, Warren RP, Caldwell VD, Hughes BG. Echinacea-induced cytokine production by human macrophages. Int J Immunopharmacol. 1997;19:371-379.
47. Fugh-Berman A. Echinacea for the prevention and treatment of upper respiratory infections. Sem Integ Med. 2003;1(6):106-111.
48. Pinto MD, Kown Y, Apostolidis E, Lajolo FM, Genovese MI, Shetty K. Potential of Ginkgo biloba L leaves in the management of hyperglycemia and hypertension using in vitro models. Bioresour Technol. 2009;100:6599-6609.
49. Hausen BM. The sensitizing capacity of ginkgolic acids in guinea pigs. Am J Contact Dermat. 1998; 9(3):146-148.
50. Liu ZH, Zeng S. Cytotoxicity of ginkgolic acid in HepG2 cells and primary rat hepatocytes. Toxicol Lett. 2009;187(3):131-136.
51. Barbara A, Dagmar S, Christine S, Susanne K, Josef K. Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. Eur J Pharmacol. 2001;430(1):1-7.
52. Bombardelli E. Approaches to the quality characteristics of medicinal plant derivatives. Eur Phytoj. 1998;1:30-33.
53. Guliyev VB, Gul M, Yildirim A. Hippophae rhamnoides L: chromatographic methods to determine chemical composition use in traditional medicine and pharmacological effects. J Chromatography B. 2004;812(1-2):291-307.
54. Wen D, Liu Y, Li W, Liu H. Separation methods for the antibacterial and antirheumatism agents in plant medicines. J Chromatography B. 2004; 812(1-2): 101-117.
55. Liang Y-Z, Xie P, Chan K. Quality control of herbal medicine. J Chromatography B. 2004;812(1-2): 53-70.
56. Joshi K, Chavan P, Warude D, Patwardhan B. Molecular markers in herbal drug technology. Curr Sci. 2004;87:159-165.
57. Mukherjee PK, Rai S, Bhattacharya S, Wahile A, Saha BP. Marker analysis of polyherbal formulation, Triphala: a well known Indian traditional medicine. Indian J Trad Knowl. 2008;7:379-383.
58. Ministry of Health and Family Welfare, Depart ment of ISM and H. The Ayurvedic Pharmacopoeia of India, Part I, Vol. III. 2001.
59. Ministry of Health and Family Welfare, Government of India. Indian Pharmacopoeia, 3rd ed., Vol. II. 1996.
60. Mukherjee PK, Sahoo AK, Narayanan N, Satheeshkumar N, Ponnusankar S. Lead finding from medicinal plants with hepatoprotective potentials. Expert Opin Drug Discov. 2009;4: 545-576.
61. Mukherjee PK, Wahile A, Kumar V, Rai S, Mukherjee K. Marker profiling for a few botanicals used for hepatoprotection in Indian system of medicine. Drug Inf J. 2006;40:131-139.